131 related articles for article (PubMed ID: 38326202)
1. Donor Age Correlates With Liver-Resident Natural Killer Cell Activity in Adoptive Immunotherapy Using Donor Liver Natural Killer Cells in Liver Transplantation.
Ohira M; Imaoka K; Bekki T; Sato K; Imaoka Y; Nakano R; Yano T; Doskali M; Shimizu S; Chogahara I; Sato S; Nakamura M; Tanaka Y; Ohdan H
Transplant Proc; 2024 Apr; 56(3):667-671. PubMed ID: 38326202
[TBL] [Abstract][Full Text] [Related]
2. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.
Ohira M; Nishida S; Tryphonopoulos P; Tekin A; Selvaggi G; Moon J; Levi D; Ricordi C; Ishiyama K; Tanaka Y; Ohdan H; Tzakis AG
Cell Transplant; 2012; 21(7):1397-406. PubMed ID: 22469170
[TBL] [Abstract][Full Text] [Related]
3. Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma.
Ohira M; Hotta R; Tanaka Y; Matsuura T; Tekin A; Selvaggi G; Vianna R; Ricordi C; Ruiz P; Nishida S; Tzakis AG; Ohdan H
Cancer Immunol Immunother; 2022 Mar; 71(3):589-599. PubMed ID: 34282496
[TBL] [Abstract][Full Text] [Related]
4. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T
Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347
[TBL] [Abstract][Full Text] [Related]
5. Liver natural killer cell inoculum for liver transplantation with hepatocellular carcinoma.
Nishida S; Levi DM; Tzakis AG
Curr Opin Organ Transplant; 2013 Dec; 18(6):690-4. PubMed ID: 24220052
[TBL] [Abstract][Full Text] [Related]
6. Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver Transplantation.
Tanimine N; Ohira M; Kurita E; Nakano R; Sakai H; Tahara H; Ide K; Kobayashi T; Tanaka Y; Ohdan H
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339284
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
[TBL] [Abstract][Full Text] [Related]
8. Adoptive immunotherapy overcomes genetic susceptibility to bloodstream infections due to fc-gamma receptor polymorphisms after liver transplantation.
Shimizu S; Ohira M; Tanaka Y; Ide K; Tahara H; Kuroda S; Tanimine N; Doskali M; Hotta R; Yano T; Nakano R; Imaoka Y; Sato K; Imaoka K; Kobayashi T; Ohdan H
Am J Transplant; 2022 Oct; 22(10):2392-2400. PubMed ID: 35670552
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma.
Imaoka K; Ohira M; Hattori M; Chogahara I; Sato S; Nakamura M; Bekki T; Sato K; Imaoka Y; Nakano R; Yano T; Sakai H; Kuroda S; Tahara H; Ide K; Kobayashi T; Tanaka Y; Ohdan H
Transplant Proc; 2024 Apr; 56(3):634-639. PubMed ID: 38443302
[TBL] [Abstract][Full Text] [Related]
10. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of T-cell depletion method for clinical immunotherapy-anti-hepatitis c effects of natural killer cells via interferon-γ production.
Ohira M; Nishida S; Matsuura T; Muraoka I; Tryphonopoulos P; Fan J; Tekin A; Selvaggi G; Levi D; Ruiz P; Ricordi C; Ohdan H; Tzakis AG
Transplant Proc; 2013 Jun; 45(5):2045-50. PubMed ID: 23769105
[TBL] [Abstract][Full Text] [Related]
12. Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
Tanimine N; Tanaka Y; Abe T; Piao J; Chayama K; Ohdan H
Transplantation; 2016 Feb; 100(2):355-64. PubMed ID: 26714120
[TBL] [Abstract][Full Text] [Related]
13. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
14. Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation.
Imaoka K; Ohira M; Bekki T; Sato K; Imaoka Y; Nakano R; Yano T; Sakai H; Tanimine N; Shimizu S; Doskali M; Kuroda S; Tahara H; Ide K; Kobayashi T; Tanaka Y; Ohdan H
Transplant Proc; 2023 May; 55(4):906-912. PubMed ID: 37095010
[TBL] [Abstract][Full Text] [Related]
15. MELD and Child-Pugh Scores Are Related to Immune Status of Intrahepatic Natural Killer Cells in Liver Transplant Candidates.
Tanimine N; Tanaka Y; Abe T; Piao J; Ishiyama K; Kobayashi T; Ide K; Ohira M; Tahara H; Shimizu S; Saeki Y; Sakai H; Yano T; Ohdan H
Transplant Proc; 2017; 49(1):98-101. PubMed ID: 28104168
[TBL] [Abstract][Full Text] [Related]
16. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line.
Shman TV; Vashkevich KP; Migas AA; Matveyenka MA; Lasiukov YA; Mukhametshyna NS; Horbach KI; Aleinikova OV
Clin Exp Med; 2023 Oct; 23(6):2551-2560. PubMed ID: 36527513
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function.
Carreira-Santos S; López-Sejas N; González-Sánchez M; Sánchez-Hernández E; Pera A; Hassouneh F; Durán E; Solana R; Casado JG; Tarazona R
Front Immunol; 2023; 14():1256404. PubMed ID: 37908353
[TBL] [Abstract][Full Text] [Related]
19. Differential function of natural killer cells in the liver graft perfusate of Korean population.
Kim N; Park PJ; Jung MK; Song GW; Jung DH; Lee SG; Ahn CS; Hwang S
Transplant Proc; 2013 Oct; 45(8):2886-91. PubMed ID: 24156998
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cells in the treatment of high-risk acute leukaemia.
Locatelli F; Moretta F; Brescia L; Merli P
Semin Immunol; 2014 Apr; 26(2):173-9. PubMed ID: 24613727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
